Biopharma Resilience Testimonial: Bionova Scientific

The COVID-19 pandemic was a worldwide lesson on the importance of flexibility and agility required for today's manufacturers to respond to demands for life-changing therapeutics. Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future. More on www.cytiva.com/resilience

Thursday, June 2, 2022 | 4:12

Biopharma Resilience Testimonial: Bionova Scientific 4:12
Biopharma Resilience Testimonial: Arranta Bio 4:10
Biopharma Resilience Testimonial: Lakes Bioscience and NHC 4:12